← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 31, 2014Last known activity
May 2, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05932979Lead sponsorPhase 2May 2, 2023
- NCT05932979Reponsible party - principal investigatorPhase 2May 2, 2023
- NCT05932979Sponsor investigatorPhase 2May 2, 2023
- NCT05712044Lead sponsorN/AFeb 1, 2023
- NCT05712044Overall official - principal investigatorN/AFeb 1, 2023
- NCT05712044Reponsible party - principal investigatorN/AFeb 1, 2023
- NCT03770611CollaboratorN/AJan 7, 2019
- NCT03374176Reponsible party - principal investigatorPhase 3Mar 31, 2014
- NCT03374176Lead sponsorPhase 3Mar 31, 2014
Details
- Last known activity
- May 2, 2023